BGI Genomics Co., Ltd. (SHE: 300676)
China
· Delayed Price · Currency is CNY 39.73
-0.87 (-2.14%)
Jan 3, 2025, 3:04 PM CST
BGI Genomics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 4,015 | 4,333 | 7,036 | 6,754 | 8,387 | 2,794 | Upgrade
|
| Other Revenue | 16.91 | 16.91 | 16.67 | 11.75 | 10.31 | 6.68 | Upgrade
|
| Revenue | 4,032 | 4,350 | 7,053 | 6,766 | 8,397 | 2,800 | Upgrade
|
| Revenue Growth (YoY) | -29.00% | -38.33% | 4.24% | -19.42% | 199.86% | 10.41% | Upgrade
|
| Cost of Revenue | 2,125 | 2,202 | 3,528 | 2,845 | 3,382 | 1,301 | Upgrade
|
| Gross Profit | 1,907 | 2,147 | 3,526 | 3,921 | 5,015 | 1,500 | Upgrade
|
| Selling, General & Admin | 1,341 | 1,441 | 1,998 | 1,637 | 1,630 | 827.42 | Upgrade
|
| Research & Development | 532.93 | 523.23 | 526.46 | 474.79 | 611.32 | 306.15 | Upgrade
|
| Other Operating Expenses | 14.58 | 4.1 | -89 | 24.06 | -10.23 | 8.94 | Upgrade
|
| Operating Expenses | 2,045 | 2,035 | 2,620 | 2,241 | 2,372 | 1,242 | Upgrade
|
| Operating Income | -137.64 | 112.94 | 905.27 | 1,680 | 2,643 | 257.59 | Upgrade
|
| Interest Expense | -74.53 | -91.56 | -100.76 | -104.72 | -89.04 | -5.73 | Upgrade
|
| Interest & Investment Income | 122.36 | 153.33 | 424.36 | 218.16 | 119.22 | 16.74 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.36 | -11.36 | -2.27 | -39.76 | -138.51 | 5.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 24.26 | -6.44 | -91.43 | -4.04 | -35.45 | -4.26 | Upgrade
|
| EBT Excluding Unusual Items | -76.91 | 156.91 | 1,135 | 1,750 | 2,499 | 269.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | -25.37 | -34.36 | 80.73 | 86.41 | 52.2 | 11.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.22 | 2.76 | 0.11 | -3.88 | -4.23 | 2.69 | Upgrade
|
| Asset Writedown | 2.26 | -9.25 | -209.24 | -102.24 | -105.02 | -1.2 | Upgrade
|
| Other Unusual Items | -0.53 | -0.53 | 0.02 | 15.87 | 0 | 45.6 | Upgrade
|
| Pretax Income | -98.33 | 115.54 | 1,007 | 1,746 | 2,442 | 328.19 | Upgrade
|
| Income Tax Expense | 2.32 | 21.85 | 197.51 | 268.19 | 340.24 | 49.67 | Upgrade
|
| Earnings From Continuing Operations | -100.65 | 93.68 | 809.29 | 1,478 | 2,102 | 278.52 | Upgrade
|
| Minority Interest in Earnings | -0.97 | -0.78 | -6.52 | -16.16 | -11.77 | -2.19 | Upgrade
|
| Net Income | -101.62 | 92.9 | 802.77 | 1,462 | 2,090 | 276.33 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.4 | - | Upgrade
|
| Net Income to Common | -101.62 | 92.9 | 802.77 | 1,462 | 2,089 | 276.33 | Upgrade
|
| Net Income Growth | - | -88.43% | -45.07% | -30.08% | 656.43% | -28.53% | Upgrade
|
| Shares Outstanding (Basic) | 406 | 410 | 410 | 410 | 398 | 400 | Upgrade
|
| Shares Outstanding (Diluted) | 406 | 412 | 410 | 412 | 399 | 400 | Upgrade
|
| Shares Change (YoY) | -2.79% | 0.48% | -0.32% | 3.11% | -0.20% | -0.00% | Upgrade
|
| EPS (Basic) | -0.25 | 0.23 | 1.96 | 3.56 | 5.25 | 0.69 | Upgrade
|
| EPS (Diluted) | -0.25 | 0.23 | 1.96 | 3.55 | 5.24 | 0.69 | Upgrade
|
| EPS Growth | - | -88.48% | -44.90% | -32.25% | 658.65% | -28.53% | Upgrade
|
| Free Cash Flow | -570.87 | -827.62 | -1,136 | 2,093 | 3,302 | -402.18 | Upgrade
|
| Free Cash Flow Per Share | -1.41 | -2.01 | -2.77 | 5.08 | 8.27 | -1.01 | Upgrade
|
| Dividend Per Share | 0.100 | 0.100 | 1.000 | 0.350 | 0.350 | 0.100 | Upgrade
|
| Dividend Growth | -90.00% | -90.00% | 185.71% | 0% | 250.00% | -66.67% | Upgrade
|
| Gross Margin | 47.30% | 49.37% | 49.99% | 57.95% | 59.72% | 53.56% | Upgrade
|
| Operating Margin | -3.41% | 2.60% | 12.83% | 24.83% | 31.48% | 9.20% | Upgrade
|
| Profit Margin | -2.52% | 2.14% | 11.38% | 21.60% | 24.88% | 9.87% | Upgrade
|
| Free Cash Flow Margin | -14.16% | -19.03% | -16.10% | 30.93% | 39.32% | -14.36% | Upgrade
|
| EBITDA | 210.03 | 464.67 | 1,262 | 1,959 | 2,945 | 498.67 | Upgrade
|
| EBITDA Margin | 5.21% | 10.68% | 17.90% | 28.95% | 35.08% | 17.81% | Upgrade
|
| D&A For EBITDA | 347.67 | 351.73 | 357.13 | 278.78 | 302.33 | 241.08 | Upgrade
|
| EBIT | -137.64 | 112.94 | 905.27 | 1,680 | 2,643 | 257.59 | Upgrade
|
| EBIT Margin | -3.41% | 2.60% | 12.83% | 24.83% | 31.48% | 9.20% | Upgrade
|
| Effective Tax Rate | - | 18.92% | 19.62% | 15.36% | 13.93% | 15.13% | Upgrade
|
| Revenue as Reported | 4,032 | 4,350 | 7,053 | 6,766 | - | 2,800 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.